Amylin and Syndrome-X.
- Published in:
- Drug Development Research, 1994, v. 32, n. 2, p. 90, doi. 10.1002/ddr.430320205
- By:
- Publication type:
- Article
Works matching IS 02724391 AND DT 1994 AND VI 32 AND IP 2
Results: 9
1
2
Masthead.
- Published in:
- Drug Development Research, 1994, v. 32, n. 2, p. fmi, doi. 10.1002/ddr.430320201
- Publication type:
- Article
3
Rationale for activation of adenosine A<sub>1</sub> receptors in adipocytes in the treatment of non-insulin-dependent diabetes mellitus.
- Published in:
- Drug Development Research, 1994, v. 32, n. 2, p. 126, doi. 10.1002/ddr.430320209
- By:
- Publication type:
- Article
4
Attenuation of experimental hypertension with agents that increase insulin sensitivity.
- Published in:
- Drug Development Research, 1994, v. 32, n. 2, p. 100, doi. 10.1002/ddr.430320206
- By:
- Publication type:
- Article
5
Antidiabetic and antiobesity effects of a highly selective β<sub>3</sub>-adrenoceptor agonist (CL 316,243).
- Published in:
- Drug Development Research, 1994, v. 32, n. 2, p. 69, doi. 10.1002/ddr.430320203
- By:
- Publication type:
- Article
6
Diabetic nephropathy, renal hemodynamics, and aldose reductase inhibitors.
- Published in:
- Drug Development Research, 1994, v. 32, n. 2, p. 104, doi. 10.1002/ddr.430320207
- By:
- Publication type:
- Article
7
Editorial.
- Published in:
- Drug Development Research, 1994, v. 32, n. 2, p. 67, doi. 10.1002/ddr.430320202
- By:
- Publication type:
- Article
8
Advanced glycosylation endproducts: Role in diabetic and non-diabetic vascular disease.
- Published in:
- Drug Development Research, 1994, v. 32, n. 2, p. 77, doi. 10.1002/ddr.430320204
- By:
- Publication type:
- Article
9
Developmental aspects of the Adipose tissue renin-angiotensin system: Therapeutic implications.
- Published in:
- Drug Development Research, 1994, v. 32, n. 2, p. 117, doi. 10.1002/ddr.430320208
- By:
- Publication type:
- Article